Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci.

Sparfloxacin, a new fluorinated quinolone, exhibits higher in vitro activity against pneumococci than do ciprofloxacin and ofloxacin. Since up to 30% of cases of pneumococcal pneumonia are associated with bacteremia, and since an increasing percentage of pneumococci are resistant against penicillin,...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Trautmann, M, Ruhnke, M, Borner, K, Wagner, J, Koeppe, P
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163197/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8851610/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.3.776
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!